Isthmus Partners LLC maintained its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, Holdings Channel reports. The firm owned 9,687 shares of the pharmacy operator’s stock at the end of the first quarter. Isthmus Partners LLC’s holdings in Walgreens Boots Alliance were worth $805,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of WBA. Hudock Capital Group LLC boosted its position in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares during the period. Tarbox Group Inc. boosted its position in shares of Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 1,006 shares during the period. Howe & Rusling Inc. boosted its position in shares of Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator’s stock valued at $120,000 after buying an additional 975 shares during the period. Webster Bank N. A. boosted its position in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after buying an additional 235 shares during the period. Finally, Orrstown Financial Services Inc. boosted its position in shares of Walgreens Boots Alliance by 13.9% in the first quarter. Orrstown Financial Services Inc. now owns 1,515 shares of the pharmacy operator’s stock valued at $126,000 after buying an additional 185 shares during the period. Institutional investors and hedge funds own 61.17% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (WBA) opened at 81.06 on Monday. The stock has a market cap of $86.74 billion, a price-to-earnings ratio of 20.47 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $88.00. The firm has a 50-day moving average price of $78.82 and a 200-day moving average price of $82.40.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same quarter last year, the business earned $1.18 earnings per share. Walgreens Boots Alliance’s revenue was up 2.1% compared to the same quarter last year. Analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.97%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 37.78%.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/07/walgreens-boots-alliance-inc-nasdaqwba-position-maintained-by-isthmus-partners-llc.html.

WBA has been the topic of several recent research reports. Morgan Stanley restated an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday. Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Jefferies Group LLC dropped their price target on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 31st. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $90.69.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.